Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medicure (MCUJF) EPS (Weighted Average and Diluted) (2016 - 2025)

Medicure has reported EPS (Weighted Average and Diluted) over the past 15 years, most recently at -$8375.0 for Q2 2025.

  • For Q2 2025, EPS (Weighted Average and Diluted) rose 79.35% year-over-year to -$8375.0; the TTM value through Jun 2025 reached -$8375.0, up 79.35%, while the annual FY2025 figure was -$0.49, 581.18% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q2 2025 was -$8375.0 at Medicure, up from -$8828.6 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $68000.0 in Q3 2024 and troughed at -$40566.7 in Q2 2024.
  • A 5-year average of $2691.9 and a median of $2596.2 in 2022 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 1208.87% in 2023 and later surged 4315.58% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at $20978.1 in 2021, then tumbled by 83.35% to $3492.3 in 2022, then tumbled by 1208.87% to -$38725.0 in 2023, then surged by 83.83% to -$6260.0 in 2024, then tumbled by 33.79% to -$8375.0 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for MCUJF at -$8375.0 in Q2 2025, -$8828.6 in Q1 2025, and -$6260.0 in Q4 2024.